Novavax, Inc.

NASDAQ:NVAX

Biotechnology

Healthcare
$7.72 -1.84%

-$0.18 today

Market cap
$1.27B
Beta
2.41
P/E (TTM)
-17.3
EPS (TTM)
-$0.54
52W Low $6.13High $11.97

Volume 4.34M

Average 4.58M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.18B

FY 2025 · Annual

-24.6% YoY

Liabilities

$1.30B

FY 2025 · Annual

-40.3% YoY

Equity

-$127.75M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.52B1.34B568.51M530.23M240.63M
Short-term Investments000392.89M494.45M
Net Receivables454.99M82.38M297.24M108.29M106.45M
Inventory8.87M36.68M41.7M8.75M11.55M
Other Current Assets56.11M86.68M166.15M32.51M125.2M
Total Current Assets2.16B1.7B1.14B1.13B978.28M
Property, Plant & Equipment (Net)228.7M400.49M490.99M300M67.7M
Goodwill131.48M126.33M127.45M107.48M113.46M
Intangible Assets4.77M0000
Long-term Investments1.65M1.66M000
Tax Assets(1.65M)(1.66M)000
Other Non-current Assets56.69M28.47M35.16M24M17.08M
Total Non-current Assets421.63M555.29M653.6M431.48M198.24M
Total Assets2.58B2.26B1.8B1.56B1.18B
Account Payables127.05M216.52M132.61M41.58M24.58M
Short-term Debt0324.88M000
Tax Payables00000
Deferred Revenue1.42B370.14M241.31M675.07M140.05M
Other Current Liabilities74.48M982.62M917.36M279.95M236.62M
Total Current Liabilities2.39B2.46B1.64B1.15B459.95M
Long-term Debt323.46M166.47M168.02M169.68M244.21M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)172.53M179.41M622.21M446.82M358.94M
Other Non-current Liabilities42.12M55.7M33.13M359.61M239.07M
Total Non-current Liabilities538.11M432.81M879.28M1.03B844.32M
Total Liabilities2.93B2.89B2.51B2.18B1.3B
Common Stock764K868K1.41M1.62M1.65M
Retained Earnings(3.62B)(4.28B)(4.82B)(5.01B)(4.57B)
Accumulated OCI(1.35M)(6.38M)2.72M(22.56M)2.01M
Other Stockholders Equity00000
Minority Interest00000
Total Equity(351.67M)(634.08M)(716.93M)(623.84M)(127.75M)
Total Debt453.99M549.78M229.08M230.42M248.81M
Net Debt(1.06B)(787.1M)(339.42M)(299.81M)8.18M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$228.4M
Short-term Investments$562.0M
Receivables$23.3M
Inventory$11.5M
Other Current$25.7M
Total Current Assets$850.8M
PP&E (Net)$63.5M
Goodwill$112.9M
Other Non-current$16.0M
Total Non-current Assets$192.3M
Total Assets$1.0B

Analysis

Selected assets total $1.0B for Latest. The largest visible component is Short-term Investments at $562.0M, about 53.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportOct 29, 2026
SC 13D/ASC 13D/A filingOct 16, 2026

How much cash does NVAX have?

Novavax, Inc. (NVAX) reported $240.63M in cash and equivalents in fiscal 2025.

How much debt does NVAX carry?

Novavax, Inc. (NVAX) reported $248.81M of total debt, with net debt of $8.18M.